Cargando…
Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant
Disturbances in lipid metabolism related to excessive food intake and sedentary lifestyle are among major risk of various metabolic disorders. Stearoyl-CoA desaturase-1 (SCD1) has an essential role in these diseases, as it catalyzes the synthesis of unsaturated fatty acids, both supplying for fat st...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181825/ https://www.ncbi.nlm.nih.gov/pubmed/35682900 http://dx.doi.org/10.3390/ijms23116221 |
_version_ | 1784723879435960320 |
---|---|
author | Tibori, Kinga Orosz, Gabriella Zámbó, Veronika Szelényi, Péter Sarnyai, Farkas Tamási, Viola Rónai, Zsolt Mátyási, Judit Tóth, Blanka Csala, Miklós Kereszturi, Éva |
author_facet | Tibori, Kinga Orosz, Gabriella Zámbó, Veronika Szelényi, Péter Sarnyai, Farkas Tamási, Viola Rónai, Zsolt Mátyási, Judit Tóth, Blanka Csala, Miklós Kereszturi, Éva |
author_sort | Tibori, Kinga |
collection | PubMed |
description | Disturbances in lipid metabolism related to excessive food intake and sedentary lifestyle are among major risk of various metabolic disorders. Stearoyl-CoA desaturase-1 (SCD1) has an essential role in these diseases, as it catalyzes the synthesis of unsaturated fatty acids, both supplying for fat storage and contributing to cellular defense against saturated fatty acid toxicity. Recent studies show that increased activity or over-expression of SCD1 is one of the contributing factors for type 2 diabetes mellitus (T2DM). We aimed to investigate the impact of the common missense rs2234970 (M224L) polymorphism on SCD1 function in transfected cells. We found a higher expression of the minor Leu224 variant, which can be attributed to a combination of mRNA and protein stabilization. The latter was further enhanced by various fatty acids. The increased level of Leu224 variant resulted in an elevated unsaturated: saturated fatty acid ratio, due to higher oleate and palmitoleate contents. Accumulation of Leu224 variant was found in a T2DM patient group, however, the difference was statistically not significant. In conclusion, the minor variant of rs2234970 polymorphism might contribute to the development of obesity-related metabolic disorders, including T2DM, through an increased intracellular level of SCD1. |
format | Online Article Text |
id | pubmed-9181825 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91818252022-06-10 Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant Tibori, Kinga Orosz, Gabriella Zámbó, Veronika Szelényi, Péter Sarnyai, Farkas Tamási, Viola Rónai, Zsolt Mátyási, Judit Tóth, Blanka Csala, Miklós Kereszturi, Éva Int J Mol Sci Article Disturbances in lipid metabolism related to excessive food intake and sedentary lifestyle are among major risk of various metabolic disorders. Stearoyl-CoA desaturase-1 (SCD1) has an essential role in these diseases, as it catalyzes the synthesis of unsaturated fatty acids, both supplying for fat storage and contributing to cellular defense against saturated fatty acid toxicity. Recent studies show that increased activity or over-expression of SCD1 is one of the contributing factors for type 2 diabetes mellitus (T2DM). We aimed to investigate the impact of the common missense rs2234970 (M224L) polymorphism on SCD1 function in transfected cells. We found a higher expression of the minor Leu224 variant, which can be attributed to a combination of mRNA and protein stabilization. The latter was further enhanced by various fatty acids. The increased level of Leu224 variant resulted in an elevated unsaturated: saturated fatty acid ratio, due to higher oleate and palmitoleate contents. Accumulation of Leu224 variant was found in a T2DM patient group, however, the difference was statistically not significant. In conclusion, the minor variant of rs2234970 polymorphism might contribute to the development of obesity-related metabolic disorders, including T2DM, through an increased intracellular level of SCD1. MDPI 2022-06-02 /pmc/articles/PMC9181825/ /pubmed/35682900 http://dx.doi.org/10.3390/ijms23116221 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tibori, Kinga Orosz, Gabriella Zámbó, Veronika Szelényi, Péter Sarnyai, Farkas Tamási, Viola Rónai, Zsolt Mátyási, Judit Tóth, Blanka Csala, Miklós Kereszturi, Éva Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant |
title | Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant |
title_full | Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant |
title_fullStr | Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant |
title_full_unstemmed | Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant |
title_short | Molecular Mechanisms Underlying the Elevated Expression of a Potentially Type 2 Diabetes Mellitus Associated SCD1 Variant |
title_sort | molecular mechanisms underlying the elevated expression of a potentially type 2 diabetes mellitus associated scd1 variant |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181825/ https://www.ncbi.nlm.nih.gov/pubmed/35682900 http://dx.doi.org/10.3390/ijms23116221 |
work_keys_str_mv | AT tiborikinga molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant AT oroszgabriella molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant AT zamboveronika molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant AT szelenyipeter molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant AT sarnyaifarkas molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant AT tamasiviola molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant AT ronaizsolt molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant AT matyasijudit molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant AT tothblanka molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant AT csalamiklos molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant AT kereszturieva molecularmechanismsunderlyingtheelevatedexpressionofapotentiallytype2diabetesmellitusassociatedscd1variant |